GSK Stock Ownership Activity

GLAXOSMITHKLINE PLC-SPON ADR 13F holders

1 value investing guru has made changes to the GLAXOSMITHKLINE PLC-SPON ADR (GSK) position according to the gurus' latest SEC quarterly report(s). GSK has been completely sold out by 1 guru(s)

Which gurus or hedge funds are buying GSK now?

According to the latest SEC filing(s) GLAXOSMITHKLINE PLC-SPON ADR (GSK) has not been purchased by any super investor.

To see more about who is investing in GLAXOSMITHKLINE PLC-SPON ADR (GSK), please go to the GSK ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2020 Q1 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-2.77%
-35,208
-0.31%
10.70%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-3.73%
-5,102
-0.01%
0.29%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-9.45%
-2,336,240
-0.22%
2.08%
Current price: $40.50 14.49% AVG reported price*: $47.36
2019 Q4 (4 results)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.55%
-2,160
-0.00%
0.29%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-2.03%
-26,377
-0.19%
9.05%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-3.22%
-823,840
-0.07%
1.97%
Jim Cullen
Cullen Value Fund
-28.07%
-5,300
-1.04%
2.66%
Current price: $40.50 31.05% AVG reported price*: $58.74
2019 Q3 (4 results)
Jim Cullen
Cullen Value Fund
buy
+18,880
+2.59%
2.59%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
buy
+25,548,000
+2.01%
2.01%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+0.97%
+12,468
+0.08%
8.67%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-3.57%
-5,151
-0.01%
0.26%
Current price: $40.50 24.09% AVG reported price*: $53.35
2019 Q2 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+25.73%
+262,771
+1.64%
8.03%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-4.41%
-6,649
-0.01%
0.25%
Sarah Ketterer
Causeway Capital Management
-100.00%
-1,138
-0.00%
0.00%
Current price: $40.50 19.04% AVG reported price*: $50.02
2019 Q1 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+1.24%
+12,488
+0.10%
8.33%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.42%
-642
-0.00%
0.26%
Sarah Ketterer
Causeway Capital Management
-99.50%
-226,535
-0.12%
0.00%
Current price: $40.50 22.47% AVG reported price*: $52.24
2018 Q4 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+1.56%
+15,539
+0.13%
8.69%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-2.10%
-3,246
-0.01%
0.26%
Sarah Ketterer
Causeway Capital Management
-27.02%
-84,311
-0.05%
0.13%
Current price: $40.50 15.21% AVG reported price*: $47.76
2018 Q3 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+0.40%
+3,939
+0.03%
7.66%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.35%
-549
-0.00%
0.23%
Sarah Ketterer
Causeway Capital Management
-9.00%
-30,837
-0.02%
0.16%
Current price: $40.50 19.34% AVG reported price*: $50.21
2018 Q2 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+0.48%
+4,760
+0.04%
7.93%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.05%
-70
-0.00%
0.24%
Sarah Ketterer
Causeway Capital Management
-53.46%
-393,801
-0.20%
0.17%
Current price: $40.50 19.62% AVG reported price*: $50.39
2018 Q1 (3 results)
Sarah Ketterer
Causeway Capital Management
+46.12%
+232,492
+0.12%
0.39%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+8.03%
+73,184
+0.57%
7.66%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.61%
-2,545
-0.00%
0.23%
Current price: $40.50 17.07% AVG reported price*: $48.84
2017 Q4 (3 results)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
+80.66%
+70,464
+0.09%
0.19%
Sarah Ketterer
Causeway Capital Management
+14.39%
+63,402
+0.03%
0.24%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+11.56%
+94,422
+0.66%
6.35%
Current price: $40.50 8.65% AVG reported price*: $44.34
2017 Q3 (3 results)
Sarah Ketterer
Causeway Capital Management
+29.61%
+100,690
+0.06%
0.25%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.36%
-312
-0.00%
0.12%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-3.22%
-27,160
-0.21%
6.33%
Current price: $40.50 20.20% AVG reported price*: $50.75
2017 Q2 (3 results)
Sarah Ketterer
Causeway Capital Management
+34.72%
+87,626
+0.06%
0.23%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+0.39%
+3,272
+0.03%
6.94%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.90%
-796
-0.00%
0.14%
Current price: $40.50 24.86% AVG reported price*: $53.90
2017 Q1 (4 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+26.12%
+174,144
+1.58%
7.62%
Sarah Ketterer
Causeway Capital Management
+7.11%
+16,764
+0.01%
0.18%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-3.37%
-3,087
-0.00%
0.13%
Francis Chou
Chou Associates Management
-100.00%
-14,400
-0.12%
0.00%
Current price: $40.50 23.15% AVG reported price*: $52.70
2016 Q4 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+31.85%
+161,020
+1.31%
5.42%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.35%
-325
-0.00%
0.14%
Sarah Ketterer
Causeway Capital Management
-10.04%
-26,287
-0.02%
0.19%
Current price: $40.50 15.13% AVG reported price*: $47.72
2016 Q3 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+66.18%
+201,364
+1.97%
4.96%
Sarah Ketterer
Causeway Capital Management
-0.72%
-1,906
-0.00%
0.26%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.41%
-1,318
-0.00%
0.15%
Current price: $40.50 24.97% AVG reported price*: $53.98
48 of 125

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.